|
ZKSCAN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.51860000130455E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.132100E-02 |
| Stage1-vs-Stage3 |
1.453630E-01 |
| Stage1-vs-Stage4 |
1.192180E-02 |
| Stage2-vs-Stage3 |
1.996480E-03 |
| Stage2-vs-Stage4 |
4.048200E-04 |
| Stage3-vs-Stage4 |
2.525200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.99730010308485E-10 |
| Normal-vs-Asian |
6.66133814775094E-16 |
| Caucasian-vs-AfricanAmerican |
8.586400E-01 |
| Caucasian-vs-Asian |
7.643400E-01 |
| AfricanAmerican-vs-Asian |
9.664000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.198000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
4.40160000003686E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.770800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.137000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.882800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.919200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.635400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.354200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.58359999999913E-05 |
| Classical-VS-Follicular |
5.894500E-02 |
| Classical-VS-Other |
2.367400E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
5.51249999980463E-07 |
| Tall-VS-Other |
4.616200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.236790E-01 |
| Follicular-VS-Normal |
2.20612417223265E-12 |
| Other-VS-Normal |
1.91940000004998E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.003500E-03 |
|
|
